BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21965653)

  • 21. The use of ubiquitin lysine mutants to characterize E2-E3 linkage specificity: Mass spectrometry offers a cautionary "tail".
    Hong JH; Ng D; Srikumar T; Raught B
    Proteomics; 2015 Sep; 15(17):2910-5. PubMed ID: 26036340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.
    Honda R; Tanaka H; Yasuda H
    FEBS Lett; 1997 Dec; 420(1):25-7. PubMed ID: 9450543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E2 conjugating enzyme selectivity and requirements for function of the E3 ubiquitin ligase CHIP.
    Soss SE; Yue Y; Dhe-Paganon S; Chazin WJ
    J Biol Chem; 2011 Jun; 286(24):21277-86. PubMed ID: 21518764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural insights into the conformation and oligomerization of E2~ubiquitin conjugates.
    Page RC; Pruneda JN; Amick J; Klevit RE; Misra S
    Biochemistry; 2012 May; 51(20):4175-87. PubMed ID: 22551455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of UbcH5b~ubiquitin intermediate: insight into the formation of the self-assembled E2~Ub conjugates.
    Sakata E; Satoh T; Yamamoto S; Yamaguchi Y; Yagi-Utsumi M; Kurimoto E; Tanaka K; Wakatsuki S; Kato K
    Structure; 2010 Jan; 18(1):138-47. PubMed ID: 20152160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs.
    Kar G; Keskin O; Nussinov R; Gursoy A
    J Proteome Res; 2012 Feb; 11(2):1196-207. PubMed ID: 22149024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of a HOIP/E2~ubiquitin complex reveals RBR E3 ligase mechanism and regulation.
    Lechtenberg BC; Rajput A; Sanishvili R; Dobaczewska MK; Ware CF; Mace PD; Riedl SJ
    Nature; 2016 Jan; 529(7587):546-50. PubMed ID: 26789245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of Mdm2-MdmX E3 ligase inhibitors using a cell-based ubiquitination assay.
    Herman AG; Hayano M; Poyurovsky MV; Shimada K; Skouta R; Prives C; Stockwell BR
    Cancer Discov; 2011 Sep; 1(4):312-25. PubMed ID: 22586610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UbcH5 Interacts with Substrates to Participate in Lysine Selection with the E3 Ubiquitin Ligase CHIP.
    Kanack A; Vittal V; Haver H; Keppel T; Gundry RL; Klevit RE; Scaglione KM
    Biochemistry; 2020 Jun; 59(22):2078-2088. PubMed ID: 32401531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity.
    Poyurovsky MV; Priest C; Kentsis A; Borden KL; Pan ZQ; Pavletich N; Prives C
    EMBO J; 2007 Jan; 26(1):90-101. PubMed ID: 17170710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDM2 protein-mediated ubiquitination of numb protein: identification of a second physiological substrate of MDM2 that employs a dual-site docking mechanism.
    Sczaniecka M; Gladstone K; Pettersson S; McLaren L; Huart AS; Wallace M
    J Biol Chem; 2012 Apr; 287(17):14052-68. PubMed ID: 22337874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
    Okamoto K; Taya Y; Nakagama H
    FEBS Lett; 2009 Sep; 583(17):2710-4. PubMed ID: 19619542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms.
    de Bie P; Ciechanover A
    Cell Death Differ; 2011 Sep; 18(9):1393-402. PubMed ID: 21372847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural Diversity of Ubiquitin E3 Ligase.
    Toma-Fukai S; Shimizu T
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.
    Yang L; Song T; Cheng Q; Chen L; Chen J
    Mol Cell Biol; 2019 Feb; 39(4):. PubMed ID: 30455251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hetero-oligomerization with MdmX rescues the ubiquitin/Nedd8 ligase activity of RING finger mutants of Mdm2.
    Singh RK; Iyappan S; Scheffner M
    J Biol Chem; 2007 Apr; 282(15):10901-7. PubMed ID: 17301054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanistic insight into the allosteric activation of a ubiquitin-conjugating enzyme by RING-type ubiquitin ligases.
    Ozkan E; Yu H; Deisenhofer J
    Proc Natl Acad Sci U S A; 2005 Dec; 102(52):18890-5. PubMed ID: 16365295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical interaction between specific E2 and Hect E3 enzymes determines functional cooperativity.
    Kumar S; Kao WH; Howley PM
    J Biol Chem; 1997 May; 272(21):13548-54. PubMed ID: 9153201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RING E3-Catalyzed E2 Self-Ubiquitination Attenuates the Activity of Ube2E Ubiquitin-Conjugating Enzymes.
    Banka PA; Behera AP; Sarkar S; Datta AB
    J Mol Biol; 2015 Jul; 427(13):2290-304. PubMed ID: 25960396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mdm2 and MdmX partner to regulate p53.
    Wang X; Jiang X
    FEBS Lett; 2012 May; 586(10):1390-6. PubMed ID: 22673503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.